Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activators
Abstract:
The present disclosure provides methods of treating a cognitive disorder associated with abnormal dendritic spines, such as Fragile X Syndrome, Fragile X Associated Tremor/Ataxia Syndrome, autism, or mental retardation, using PKC activators.
Information query
Patent Agency Ranking
0/0